openPR Logo
Press release

Investigation announced for Investors in RenovaCare, Inc. (OTC: RCAR)

06-07-2021 08:03 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in RenovaCare, Inc. (OTC: RCAR) shares over potential securities laws violations by RenovaCare, Inc

An investigation for investors in RenovaCare, Inc. (OTC: RCAR) shares over potential securities laws violations by RenovaCare, Inc

An investigation was announced concerning potential securities laws violations by RenovaCare, Inc. in connection with certain financial statements was announced.

Investors who purchased shares of RenovaCare, Inc. (OTC: RCAR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by RenovaCare, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Roseland, NJ based RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications.

On May 28, 2021, the United States Securities and Exchange Commission (“SEC”) published a litigation release indicating the RenovaCare, Inc. was being charged with securities fraud. Specifically, the complaint referenced in the litigation release, filed in federal court in the Southern District of New York, alleges that in July 2017, Harmel S. Rayat, RenovaCare's controlling shareholder, arranged, and caused RenovaCare to pay for, a promotional campaign designed to increase the company's stock price." The complaint alleges that "Rayat was closely involved in directing the promotion and editing promotional materials, and arranged to funnel payments to the publisher through consultants to conceal RenovaCare's involvement in the campaign" and according to the complaint, "in January 2018, OTC Markets Group, Inc. requested RenovaCare issue a press release to explain its relationship to the promotion." Finally, the complaint alleges that "Rayat and RenovaCare then drafted and issued a press release and a Form 8-K that contained material misrepresentations and omissions denying Rayat's and the company's involvement in the promotion" and charges Rayat and RenovaCare with "violating the antifraud provisions of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder, and also charges Rayat with aiding and abetting the company's violations of those provisions." The complaint also charges RenovaCare with violating the reporting provisions of Exchange Act Section 15(d) and Rules 15d-11 and 12b-20 thereunder.

Shares of RenovaCare, Inc. (OTC: RCAR) declined to as low as $1.45 per share on June 2, 2021.

Those who purchased shares of RenovaCare, Inc. (OTC: RCAR) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in RenovaCare, Inc. (OTC: RCAR) here

News-ID: 2300000 • Views:

More Releases from Shareholders Foundation

Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) over possible Violations of Securities Laws
Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NA …
An investigation was announced for investors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) shares over potential securities laws violations by Lifecore Biomedical, Inc. Investors who purchased shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Lifecore Biomedical, Inc. regarding its business, its prospects and
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: DBI) over potential Wrongdoing by certain directors
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: D …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Designer Brands Inc. Investors who purchased shares of Designer Brands Inc. (NYSE: DBI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Designer Brands Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Columbus,
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. …
An investor, who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ), filed a lawsuit over alleged violations of Federal Securities Laws by Innoviz Technologies Ltd. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) have certain options and for certain investors are short and strict deadlines running. Deadline: May 14, 2024. NASDAQ: INVZ investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NASDAQ: IRBT)
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NA …
An investor, who purchased shares of iRobot Corporation (NASDAQ: IRBT), filed a lawsuit over alleged violations of Federal Securities Laws by iRobot Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of iRobot Corporation (NASDAQ: IRBT) have certain options and for certain investors are short and strict deadlines running. Deadline: May 7, 2024. NASDAQ: IRBT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)

All 5 Releases


More Releases for RenovaCare

Investigation announced for Long-Term Investors in shares of RenovaCare, Inc. (O …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of RenovaCare, Inc.. Investors who are current long term investors in RenovaCare, Inc. (OTC: RCAR) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in OTC: RCAR stocks follows a lawsuit filed against RenovaCare, Inc. over
OTC: RCAR Investor Alert: Deadline on September 14, 2021 in Lawsuit against Reno …
A deadline is coming up on September 14, 2021 in the lawsuit filed for certain investors of RenovaCare, Inc. (OTC: RCAR) over alleged securities laws violations by RenovaCare, Inc. Investors who purchased shares of RenovaCare, Inc. (OTC: RCAR) have certain options and there are strict and short deadlines running. Deadline: September 14, 2021. OTC: RCAR stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the
Lawsuit filed for Investors in shares of RenovaCare, Inc. (OTC: RCAR)
An investor, who purchased shares of RenovaCare, Inc. (OTC: RCAR), filed a lawsuit over alleged violations of Federal Securities Laws by RenovaCare, Inc.. Investors who purchased shares of RenovaCare, Inc. (OTC: RCAR) have certain options and for certain investors are short and strict deadlines running. Deadline: September 14, 2021. OTC: RCAR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Roseland, NJ based RenovaCare, Inc., a development-stage
Polymers Drug Delivery Market SWOT Analysis by Key Players Oncolytics Biotech, E …
The Global Polymers Drug Delivery Market outlook survey highlights the dynamics at play in each of the subsegments of Polymers Drug Delivery Industry to better elaborate current state, emerging trends and potential areas of focus. Discerning stakeholders in the Polymers Drug Delivery market will be able to use this study to evaluate opportunities and challenges in the context of an increasingly complex healthcare and life sciences marketplace. To understand big
Regenerative Artificial Skin Market Key Trends, Drivers, Opportunities and Forec …
Regenerative Artificial Skin Market - Pin-point Analysis of Market Dynamics The Regenerative Artificial Skin market is anticipated to grow in the forecast, owing to the factors such as increasing cases of burns and accidents, growing skin diseases, prevalence of pollution, increasing rates of acid attack victims and other body surgeries owing to beauty. Nevertheless, high cost of surgeries is expected to restrict the market growth during the forecast period. Various market forces
Regenrative Artificial Skin Market – Expected To Open Up New Growth Avenues In …
The Regenerative Artificial Skin market is anticipated to grow in the forecast, owing to the factors such as increasing cases of burns and accidents, growing skin diseases, prevalence of pollution, increasing rates of acid attack victims and other body surgeries owing to beauty. Nevertheless, high cost of surgeries is expected to restrict the market growth during the forecast period. Regenerative Artificial Skin is a collagen scaffold artificial skin that facilitates